drugset / Trial / NCT03771989

Treatment of Osteoarthritis With Autologous, Microfragmented Adipose Tissue.

NCT03771989 ↗

Unknown 120 enrolled Hvidovre University Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The study is a blinded, multicenter, randomized, controlled trial with participants individually randomized to one of two parallel groups: 1. The intervention group: Participants receive one intra articular injection with autologous, microfragmented adipose tissue. 2. The control group: Participants receive one intra articular injection with Saline (placebo). The objective of the study is to investigate if intra-articular injection with autologous, microfragmented adipose tissue prepared using the Lipogems system affects the patient reported outcome in patients with osteoarthritis of the knee. The primary endpoint is KOOS4 evaluated at 6 months after the intervention. Secondary endpoints are the KOOS including all five subscales evaluated after 6months, 1 and 2 years.

Timeline

Start
2019-01-01
Primary completion
2022-02-28
Completion
2024-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Autologous micro-fragmented adipose tissue Unknown — Other

Indications